Evidence map›Paper›PMID 28356532›Full record

ArticleJournal of virology2017

pH Optimum of Hemagglutinin-Mediated Membrane Fusion Determines Sensitivity of Influenza A Viruses to the Interferon-Induced Antiviral State and IFITMs.

Thomas Gerlach, Luca Hensen, Tatyana Matrosovich, Janina Bergmann, Michael Winkler, Christin Peteranderl, Hans-Dieter Klenk, Friedemann Weber, Susanne Herold, Stefan Pöhlmann and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
6.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 67 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Current Opinion in LAIV: A Matter of Parent Virus Choice.International journal of molecular sciences · 2022
    Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Endothelial Cells in Emerging Viral Infections.Frontiers in cardiovascular medicine · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Thomas GerlachInstitute of Virology, Philipps University, Marburg, Germany.
Luca HensenInstitute of Virology, Philipps University, Marburg, Germany.
Tatyana MatrosovichInstitute of Virology, Philipps University, Marburg, Germany.
Janina BergmannInstitute of Virology, Philipps University, Marburg, Germany.
Michael WinklerDeutsches Primatenzentrum, Göttingen, Germany.
Christin PeteranderlDepartment of Internal Medicine II, Universities Gießen & Marburg Lung Center, member of the German Center for Lung Research (DZL), Gießen, Germany.
Hans-Dieter KlenkInstitute of Virology, Philipps University, Marburg, Germany.
Friedemann WeberInstitute of Virology, FB10-Veterinary Medicine, Justus-Liebig-Universität, Gießen, Germany.ORCID http://orcid.org/0000-0001-9737-337X
Susanne HeroldDepartment of Internal Medicine II, Universities Gießen & Marburg Lung Center, member of the German Center for Lung Research (DZL), Gießen, Germany.
Stefan PöhlmannDeutsches Primatenzentrum, Göttingen, Germany.ORCID http://orcid.org/0000-0001-6086-9136
Mikhail MatrosovichInstitute of Virology, Philipps University, Marburg, Germany m.matrosovich@gmail.com.
Philipps University of Marburg · DEGerman Center for Lung Research · DEGerman Primate Center · DEJustus-Liebig-Universität Gießen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The replication and pathogenicity of influenza A viruses (IAVs) critically depend on their ability to tolerate the antiviral interferon (IFN) response. To determine a potential role for the IAV hemagglutinin (HA) in viral sensitivity to IFN, we studied the restriction of IAV infection in IFN-β-treated human epithelial cells by using 2:6 recombinant IAVs that shared six gene segments of A/Puerto Rico/8/1934 virus (PR8) and contained HAs and neuraminidases of representative avian, human, and zoonotic H5N1 and H7N9 viruses. In A549 and Calu-3 cells, viruses displaying a higher pH optimum of HA-mediated membrane fusion, H5N1-PR8 and H7N9-PR8, were less sensitive to the IFN-induced antiviral state than their counterparts with HAs from duck and human viruses, which fused at a lower pH. The association between a high pH optimum of fusion and reduced IFN sensitivity was confirmed by using HA point mutants of A/Hong Kong/1/1968-PR8 that differed solely by their fusion properties. Furthermore, similar effects of the viral fusion pH on IFN sensitivity were observed in experiments with (i) primary human type II alveolar epithelial cells and differentiated cultures of human airway epithelial cells, (ii) nonrecombinant zoonotic and pandemic IAVs, and (iii) preparations of IFN-α and IFN-λ1. A higher pH of membrane fusion and reduced sensitivity to IFN correlated with lower restriction of the viruses in MDCK cells stably expressing the IFN-inducible transmembrane proteins IFITM2 and IFITM3, which are known to inhibit viral fusion. Our results reveal that the pH optimum of HA-driven membrane fusion of IAVs is a determinant of their sensitivity to IFN and IFITM proteins.

Indexed as

Host-Pathogen InteractionsMembrane FusionA549 CellsAnimalsAntigens, DifferentiationCell LineDogsDucksEpithelial CellsHemagglutinin Glycoproteins, Influenza VirusHumansHydrogen-Ion ConcentrationInfluenza A Virus, H5N1 SubtypeInfluenza A Virus, H7N9 SubtypeInterferon-betaInterferonsAntigens, DifferentiationHemagglutinin Glycoproteins, Influenza VirusIFITM2 protein, humanIFITM3 protein, humanInterferon-betaInterferonsleu-13 antigenMembrane ProteinsRNA-Binding ProteinsfusionH5N1H7N9hemagglutininIFITMinfluenzainterferonrestriction

Identifiers

PMID28356532
PMCPMC5432869
OpenAlexW2599511061

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.